Twist Bioscience: Leproust proposes $8.64M share sale

The shares came from restricted stock vesting on October 1, 2026, and sale remarks identify a tax obligation resulting from the award settlement.

Rhea-AI Filing Summary

Twist Bioscience Corp. is identified as issuer in a Rule 144 notice naming officer and director Emily M. Leproust for a proposed sale of 45,736 common shares, with an aggregate market value of $8,638,789.48 and an approximate sale date of October 2, 2026. The shares were acquired from the issuer through restricted stock vesting on October 1, 2026; sale remarks state that the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution.

Key Figures

Common shares proposed for sale: 45,736 shares Aggregate market value: $8,638,789.48 Restricted stock vesting date: October 1, 2026

3 metrics

Common shares proposed for sale 45,736 shares Approximate sale date October 2, 2026

Aggregate market value $8,638,789.48 Shares listed for sale

Restricted stock vesting date October 1, 2026 Shares acquired from the issuer

Key Terms

Rule 144, Restricted Stock Vesting, attorney-in-fact, vested equity award distribution

4 terms

Rule 144 regulatory

"definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 10/01/2026 | Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Emily M. Leproust"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

vested equity award distribution financial

"settlement of a vested equity award distribution"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TWST shares does Emily M. Leproust plan to sell?

The notice lists 45,736 common shares for sale, with an aggregate market value of $8,638,789.48 and an approximate sale date of October 2, 2026. The shares were acquired from the issuer through restricted stock vesting on October 1, 2026.

Does Emily M. Leproust's TWST sale include shares for taxes?

The sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/02/2026 - 04:39 PM Accepted by SEC EDGAR 10/02/2026 - 04:38 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001753655
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Twist Bioscience Corp
SEC File Number	001-38720
Address of Issuer	681 GATEWAY BLVD. SOUTH SAN FRANCISCO CALIFORNIA 94080
Phone	800-719-0671
Name of Person for Whose Account the Securities are To Be Sold	Leproust Emily M.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	45736	8638789.48	62707424	10/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2026	Restricted Stock Vesting	Issuer			45736	10/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Emily M. Leproust 681 Gateway Blvd South San Francisco CA 94080	Common	08/03/2026	5101	435223.44
Emily M. Leproust 681 Gateway Blvd South San Francisco CA 94080	Common	08/10/2026	113318	14183062.19
Emily M. Leproust 681 Gateway Blvd South San Francisco CA 94080	Common	08/12/2026	19952	2495508.37
Emily M. Leproust 681 Gateway Blvd South San Francisco CA 94080	Common	08/21/2026	6639	923261.83
Emily M. Leproust 681 Gateway Blvd South San Francisco CA 94080	Common	08/25/2026	41570	6317760.97
Emily M. Leproust 681 Gateway Blvd South San Francisco CA 94080	Common	09/08/2026	2302	282280.22
Emily M. Leproust 681 Gateway Blvd South San Francisco CA 94080	Common	09/17/2026	356546	56330878.38
Emily M. Leproust 681 Gateway Blvd South San Francisco CA 94080	Common	09/21/2026	1687	279183.99
Emily M. Leproust 681 Gateway Blvd South San Francisco CA 94080	Common	09/24/2026	5203	922906.47
Emily M. Leproust 681 Gateway Blvd South San Francisco CA 94080	Common	10/01/2026	655	131000.00

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	10/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Emily Navaro, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Emily M. Leproust.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)